LEGN — Legend Biotech Corporation | XLV Holdings | StockAdder

(LEGN)

Legend Biotech Corporation

Live chart and latest LEGN stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

LEGN News

Legend Biotech (NASDAQ: LEGN) reports $597M preliminary CARVYKTI net trade sales

Apr 14, 2026 Yahoo Finance

RBC Capital Cuts PT on Legend Biotech Corporation (LEGN) to $62 From $66 – Here’s Why

Mar 31, 2026 simplywall.st

Why Investors Shouldn't Be Surprised By Legend Biotech Corporation's (NASDAQ:LEGN) 26% Share Price Plunge

Feb 6, 2026 Investing.com

Raymond James reiterates Legend Biotech stock rating on valuation gap

Feb 23, 2026 Quiver Quantitative

LEGEND BIOTECH ($LEGN) Releases Q4 2025 Earnings | LEGN Stock News

Mar 10, 2026 Yahoo Finance

Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions

Feb 17, 2026 Stock Titan

10,000 patients treated as Legend's CARVYKTI cell therapy tops $1.9B in 2025

Mar 10, 2026 Investing.com

RBC Capital lowers Legend Biotech stock price target on model updates

Mar 11, 2026 Yahoo Finance

Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN)

Jan 9, 2026 Stock Titan

Tax-related share sale by Legend Biotech (LEGN) CEO Ying Huang

Mar 27, 2026 Yahoo Finance

Legend Biotech (LEGN) Valuation Check After Recent Share Price Pullback

Feb 3, 2026 Stock Titan

Legend Biotech (NASDAQ: LEGN) director lists shares, options and RSUs

Mar 18, 2026 Yahoo Finance

Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline

Jan 26, 2026 Yahoo Finance

Here is Why Legend Biotech (LEGN) Offers Such Promising Upside

Dec 22, 2025 Yahoo Finance

Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects